Modern treatment approaches improve outcomes in breast cancer, suggesting that precision medicine may address therapeutic resistance and toxicity.
Modern breast cancer management is defined by precision medicine, multidisciplinary integration and less invasive surgical interventions in selected cases. Ongoing challenges include therapeutic resistance, toxicity, cost, and equitable access to innovation.
No takes yet. Share an insight, caveat, or question.
Stana et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: